Genmab — Juli 2020
-
Det ser sådan ud lige nu.
-
Puha ja.
-
Næsten 60.000 stk igennem slutauktionen.
-
Hans analyse sige vel også, at ketchupeffekten for alvor sker i det niveau?
-
Med efterfølgende mulighed for brud af 3.000.
-
-
Genmab initiated with a Sell at Societe Generale Societe Generale analyst Justin Smith initiated coverage of Genmab with a Sell rating and DKK 1,620 price target. While Smith acknowledges that 2019 was the seventh consecutive year of profitability and projects "a six-fold expansion" in annual sales from 2019-2030, he does not believe that the current share price appropriately discounts the company's portfolio concentration risk.
Read more at:
https://thefly.com/landingPageNews.php?id=3120375
or make you loose your patience because you get high on Genmab and the news ........and want more all the time. You have Genmabic i think my doctor called it!:-)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind